-
Recent Posts
Archives
Tags
access to medicines Add new tag Africa AIDS Asthma Society of Canada Bill C-51 China chronic conditions compulsory licencing Consumer Advocare Network Counterfeit drugs counterfeit medicines Department for International Development drug development drug pricing drug regulation economic development ECOSOC Europe Expert Working Group export GAVI Alliance H1N1 health care IGWG IMPACT Innovation intellectual property internet pharmacies malaria natural health products neglected diseases Pan-American Health Organization patents Patient Declaration patients patient safety Public health special interest groups Swine flu tuberculosis vaccine World Health Assembly World Health Organization World Intellectual Property Association
Blog at WordPress.com. Theme: Digg 3 Column by WP Designer
Different Perspectives on Funding Innovation – Europe vs. USA
US Health and Human Services Secretary Michael Leavitt recently spoke at a conference in Paris regarding the importance of pharmaceutical innovation. The following article demonstrates two different perspectives on funding innovation — essentially market forces vs. government price fixing.
US Health Sec warns Europe of “world without innovation”
Government price-fixing of new medicines is “the road to [...]
Filed under: Commentary on news & events | Tagged: health care, Innovation | 1 Comment »